We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$123B
1-Year Est. Return
34.51%
This Fund
S&P 500
This Quarter
Est. Return
+11%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$107B
AUM Growth
+$5.79B
(+5.7%)
Cap. Flow
-$2.7B
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
24.55%
Holding
1,462
New
74
Increased
672
Reduced
527
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$365M |
| 2 |
Procter & Gamble
PG
|
+$299M |
| 3 |
Meta Platforms (Facebook)
META
|
+$268M |
| 4 |
Republic Services
RSG
|
+$247M |
| 5 |
CRH
CRH
|
+$244M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$827M |
| 3 |
UnitedHealth
UNH
|
+$478M |
| 4 |
Microsoft
MSFT
|
+$428M |
| 5 |
NVIDIA
NVDA
|
+$347M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.15% |
| 2 | Financials | 19.67% |
| 3 | Healthcare | 11.58% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Intellia Therapeutics
NTLA
$1.5B
| $844K | ﹤0.01% |
30,692
| – | – |
|
1202
National Healthcare
NHC
$3.48B
| $841K | ﹤0.01% |
+8,900
| New | +$843K |
|
1203
HF Sinclair
DINO
$15.8B
| $839K | ﹤0.01% |
13,900
-400
| -3% | -$22.7K |
|
1204
PRA Group
PRAA
$666M
| $836K | ﹤0.01% |
32,058
| – | – |
|
1205
Futu Holdings
FUTU
$15B
| $833K | ﹤0.01% |
15,386
+4,400
| +40% | +$227K |
|
1206
Corbus Pharmaceuticals
CRBP
$165M
| $832K | ﹤0.01% |
+21,200
| New | +$523K |
|
1207
O-I Glass
OI
$1.14B
| $830K | ﹤0.01% |
50,000
-16,600
| -25% | -$263K |
|
1208
Stevanato
STVN
$5.62B
| $824K | ﹤0.01% |
+25,662
| New | +$781K |
|
1209
Crown Holdings
CCK
$13B
| $822K | ﹤0.01% |
10,369
-393
| -4% | -$32.2K |
|
1210
Gibraltar Industries
ROCK
$1.37B
| $821K | ﹤0.01% |
10,200
| – | – |
|
1211
Modine Manufacturing
MOD
$10.4B
| $819K | ﹤0.01% |
+8,600
| New | +$665K |
|
1212
HealthStream
HSTM
$828M
| $818K | ﹤0.01% |
30,700
| – | – |
|
1213
Arrowhead Research
ARWR
$12.1B
| $812K | ﹤0.01% |
+28,400
| New | +$909K |
|
1214
Middlesex Water
MSEX
$1.07B
| $811K | ﹤0.01% |
+15,444
| New | +$854K |
|
|
LAC
1215
Lithium Americas
LAC
$1.05B
| $798K | ﹤0.01% |
118,724
-80,406
| -40% | -$418K |
|
1216
Kohl's
KSS
$2.28B
| $796K | ﹤0.01% |
27,304
-14,400
| -35% | -$386K |
|
|
VERV
1217
DELISTED
Verve Therapeutics
VERV
| $795K | ﹤0.01% |
59,856
+12,800
| +27% | +$170K |
|
1218
Savers
SVV
$1.64B
| $792K | ﹤0.01% |
41,056
+4,200
| +11% | +$78.4K |
|
1219
Geron
GERN
$821M
| $788K | ﹤0.01% |
+238,800
| New | +$535K |
|
1220
Oxford Industries
OXM
$568M
| $787K | ﹤0.01% |
7,000
| – | – |
|
1221
Asbury Automotive
ABG
$4.09B
| $778K | ﹤0.01% |
3,300
+300
| +10% | +$63.7K |
|
1222
Knight Transportation
KNX
$11.1B
| $772K | ﹤0.01% |
14,035
-693
| -5% | -$39.1K |
|
1223
Trip.com Group
TCOM
$29.8B
| $769K | ﹤0.01% |
17,527
+5,200
| +42% | +$211K |
|
1224
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $765K | ﹤0.01% |
23,728
-820
| -3% | -$26.1K |
|
1225
Prelude Therapeutics
PRLD
$350M
| $761K | ﹤0.01% |
160,652
| – | – |
|
Similar funds
VAM
TD Asset Management's Q1 2024 Portfolio in Review
As of Q1 2024, TD Asset Management held 1,462 positions worth $107B, up 5.7% from $102B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
TD Asset Management's Q1 2024 filing shows 74 new, 672 increased, 527 reduced and 81 closed positions. Its largest new stake was Middleby: 121,279 shares worth $19.5M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- TD Asset Management's largest Q1 2024 buy was Middleby: 121,279 shares worth $19.5M.
- TD Asset Management added most to AbbVie in Q1 2024, an estimated $365M increase.
- TD Asset Management's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- TD Asset Management fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $59.9M.
- TD Asset Management's ten largest holdings make up 25% of its $107B portfolio in Q1 2024.
- TD Asset Management opened 74 new positions and closed 81 in Q1 2024.
- TD Asset Management's portfolio value rose 5.7% quarter-over-quarter to $107B.
Based on TD Asset Management's 13F filing for Q1 2024, filed 8 May 2024.